TI-235

N/A

Report date: 2023/08/03 16:22:14

Base Information

Drug NameTI-235

Drug Alias NameTI-235MS TCR-Treg

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionT lymphocyte replacementsMyelin basic protein modulators

TargetsMyelin basic protein

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTeraImmune Inc

China Registration ClassN/A

Develop Information

Active CompaniesTeraImmune Inc

Inactive CompaniesN/A

Active IndicationsMultiple Sclerosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A